Missed the Congress ? NO Problem

Dr Giuseppe Luigi Banna

Portsmouth Hospitals University NHS Trust, Portsmouth, UK

About this speaker

I am a Consultant Medical Oncologist for Lung and Urology tumours and Molecular Lead at the Department of Oncology of Portsmouth Hospitals University NHS Trust, UK.

In the last three years, I worked as the lead of clinical and translational research for thoracic tumours at Candiolo Cancer Institute, FPO-IRCCS, Turin, Italy, clinician scientist and consultant for lung and urology tumours at the Lincolnshire United Hospitals, the University of Lincoln and Nottingham, and Portsmouth University NHS Hospitals Trust in the UK.

I am the coordinator of the Italian Association of Medical Oncology (AIOM) clinical guidelines for testicular cancer and a referee for international research committees for cancer research.

I have been leading more than 20 clinical and translational commercial and academic studies for lung and urology cancer as Principal Investigator and joining European research networks. I published about 200 scientific papers.

My current scientific focus is on predictive models for immunotherapy and the professional objective to offer the patient the best-individualised treatment and support.

Talks

Prognostic models for immunotherapy of lung and urology cancers

07 May 2023, 08:00 AM
Dr Giuseppe Luigi Banna

Junshi Biosciences

Founded in December 2012, Junshi Biosciences (HKEX: 1877; SSE: 688180) is an innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapeutics.

Hemosure

We at Hemosure are proud to manufacture and sell the fastest-growing Immunological Fecal Immunochemical Test (FIT) and have established its place as an industry leader.

Incyte

Incyte is a global biopharmaceutical company that is focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of novel medicines.

Want to sponsor this event? Contact Us